Bio Sequence

Screening Sequences In Bulk? FTO Clearance Is Just A Few Clicks Away

1 December 2023
2 min read

Batch sequence searches are even quicker with new batch search reports and ability to save all patent results to your workspace in one click. Learn how Bio lets you search hundreds of sequences for FTO clearance in a matter of minutes!

Batch search reports summarize key results

All batch searches now generate an exportable report summarizing the key findings of your search, including the number of hits per sequence and which of those are already claimed in patents. The report can be conveniently accessed from the results page or from your search history, helping you identify top candidates in just a few clicks.

Batch save patents to Workspace!

Batch searches now allow you to batch save patents to Workspace in one go. Click to Save Patents directly from your search results, or jump to your Search History to combine and save patents from multiple batch searches. 

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

EU Commission Greenlights KAFTRIO® Paired with Ivacaftor to treat Cystic Fibrosis in Kids Aged 2-5
Latest Hotspot
3 min read
EU Commission Greenlights KAFTRIO® Paired with Ivacaftor to treat Cystic Fibrosis in Kids Aged 2-5
1 December 2023
Vertex Pharmaceuticals has announced that the European Commission has approved an expanded label for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor to treat cystic fibrosis in children aged 2 to 5 with at least one F508del mutation in the CFTR gene.
Read →
Unveiling the Secrets of IL-17A Inhibitors: Stay Updated with the Latest Advances
Unveiling the Secrets of IL-17A Inhibitors: Stay Updated with the Latest Advances
29 November 2023
IL-17A inhibitors are a class of drugs that target the cytokine IL-17A, playing a crucial role in treating inflammation and autoimmune diseases.
Read →
Initial Participant Registered for the Phase 1 Investigation of MRX-5
Latest Hotspot
3 min read
Initial Participant Registered for the Phase 1 Investigation of MRX-5
29 November 2023
Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. revealed that the first volunteer has been enlisted for the initial Phase I clinical examination of its innovative antibiotic MRX-5 in Australia.
Read →
Ruxolitinib Phosphate: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ASH
Ruxolitinib Phosphate: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ASH
29 November 2023
On 10 Dec 2023, the 3-Year final analysis of efficacy and safety of Ruxolitinib from the phase III REACH3 study will be unveiled at the 2023 ASH Congress.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.